Walmart Infant Formula Recall Issued Due to Risk of Metal Contamination

Perrigo Company is recalling more than 23,000 containers of Parent’s Choice baby formula, which was sold exclusively at Walmart, warning about a risk that metal pieces may be in the powder and harm infants.

The Walmart Parent’s Choice Advantage Infant Formula recall was posted to the FDA’s website on June 21, indicating containers may metal foreign material.

The recall came after a consumer reported finding metal pieces in one container of the formula. The manufacturer then determined one lot of Parent’s Choice Formula had the potential presence of “metal foreign matter” in a single lot, which could pose a serious risk for infants. However, no adverse events or injuries have been linked to the recalled baby formula to date.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

The action impacts affects 23,388 35-ounce, 992-gram containers of Parent’s Choice Advantage Infant Formula Milk-Based Powder with Iron. Affected products have Lot Code C26EVFV with a “use by” date of February 26, 2021, printed on the bottom of the package.

The infant formula is advertised as “complete nutrition” for a baby’s first year and retails for $19.98. The recalled baby formula containers are sold exclusively at Walmart. The formula is used by adding the powder to water and shaking.

Foreign metal debris in baby powder could result in lacerations to the mouth, choking risks and damage to internal organs.

Customers who bought the product should immediately stop using the formula and return it to Walmart for a full refund. Consumers who have experienced problems with the formula or have health-related questions should contact Perrigo Consumer Affairs at (866) 629-6181.

Any injuries or side effects should be reported to the FDA MedWatch Adverse Event Reporting Program.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery
Uber Driver Sexual Assaults and Misconduct Reports Must Be Disclosed in Lawsuit Discovery (Posted today)

A federal magistrate judge is forcing Uber to hand over potentially hundreds of thousands of incident files involving reports of passengers who suffered sexual misconduct or sexual assault at the hands of the rideshare service's drivers.

Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits
Abbott May Remove Infant Formula for Preemies Off the Market Due to Similac NEC Lawsuits (Posted yesterday)

Abbott Laboratories is considering removing Similac infant formula products designed for preterm babies from the market, as it faces hundreds of lawsuits claiming the products increase the risk of necrotizing enterocolitis, which puts newborns at a high risk of permanent injuries and death.

Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL
Information About Suboxone Dental Claims To Be Exchanged By Parties in MDL (Posted 2 days ago)

A federal judge has ordered parties involved in Suboxone dental decay lawsuits to submit proposals for exchanging information that will guide the selection of representative bellwether claims for early test trials.